Patients with higher baseline NLR were found to be at an increased risk of periprocedural PH and all-cause mortality within 3 months after TAVR.
Keyphrases
- transcatheter aortic valve replacement
- pulmonary hypertension
- aortic valve
- percutaneous coronary intervention
- aortic stenosis
- direct oral anticoagulants
- catheter ablation
- cardiovascular events
- pulmonary artery
- ejection fraction
- coronary artery disease
- venous thromboembolism
- pulmonary arterial hypertension
- acute coronary syndrome
- atrial fibrillation
- left ventricular
- cardiovascular disease